Search Results

Therapeutics

Improving Patient Access to Medication

Available services can enhance the safety of visually impaired individuals.

Richard A. Lehrer, MD

Cover Focus: The Business Of Glaucoma

Is the Grass Really Greener on the Other Side?

The pros and cons of ophthalmology business models.

Richard A. Lehrer, MD

Cover Focus: The Business Of Glaucoma

Is the Grass Really Greener on the Other Side?

The pros and cons of ophthalmology business models.

Richard A. Lehrer, MD

How Will I Alter My Practice During the Next 5 Years?

Changes in reimbursement may be a driving force.

Richard A. Lehrer, MD

Can Surgeons Perform a Better Trabeculectomy?

The procedure is still viable.

Richard A. Lehrer, MD

Glaucoma in the New Millennium

Practitioners had assimilated the innovations of the 1990s and anticipated an era of neuroprotection and bleb-free surgery.

Richard A. Lehrer, MD, Lisa F. Rosenberg, MD, and William Eric Sponsel, MD

Glaucoma in the New Millennium

Practitioners had assimilated the innovations of the 1990s and anticipated an era of neuroprotection and bleb-free surgery.

Richard A. Lehrer, MD, Lisa F. Rosenberg, MD, and William Eric Sponsel, MD

5 Questions With Garry P. Condon, MD

Dr. Condon shares his reasons for coming to and remaining in the United States as well as the inspiration for his suture fixation of an IOL.

Silicone-Oil–Related and Neovascular Glaucoma

Richard A. Lehrer, MD

Silicone-Oil–Related and Neovascular Glaucoma

Richard A. Lehrer, MD